| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 6001443 | Thrombosis Research | 2015 | 22 Pages | 
Abstract
												Extended treatment with both warfarin and DOACs are effective in preventing recurrent VTE and does not increase the risk of major bleeding, but increases the risk of NMCRB.
											Keywords
												
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Cardiology and Cardiovascular Medicine
												
											Authors
												Caroline Sindet-Pedersen, Jannik Langtved Pallisgaard, Jonas Bjerring Olesen, Gunnar Hilmar Gislason, Lourdes Cantarero Arevalo, 
											